• Health & Medicine

Cancer is biggest fear but 34 per cent put it down to fate

Cancer is the nation's number one fear but more than a third think getting the disease is down to fate and there is nothing they can do to avoid it - according to a Cancer Research UK survey out today (Wednesday). Cancer is the nation's number one fear but more than a third think getting the disease is down to fate and there is nothing they can do to avoid it - according to a Cancer Research UK survey out today (Wednesday).

8 December 2010

• Science & Technology
• Health & Medicine

Podcast: cervical cancer screening, prostate cancer treatment, lung surgery rates and a big day out at Westminster

19 November 2010

• Health & Medicine

NCRI Conference: Professor Peter Sasieni on HPV vaccination and cervical screening

10 November 2010

• Health & Medicine

HPV testing and vaccination could cut cervical screening to twice in a lifetime

Women who have had the human papillomavirus (HPV) vaccine could need only two HPV screening tests for the rest of their lives according to new calculations being presented at the NCRI Cancer Conference in Liverpool. Women who have had the human papillomavirus (HPV) vaccine could need only two HPV screening tests for the rest of their lives according to new calculations being presented at the NCRI Cancer Conference in Liverpool.

10 November 2010

• Health & Medicine
• Science & Technology

NCRI conference: How could the HPV vaccine change cervical screening?

9 November 2010

• Health & Medicine

Test selects the 60 per cent of women with inherited ovarian cancer who could benefit from 'smart' drug

Scientists have developed a new test to select which patients with ovarian cancer will benefit from new drugs called PARP inhibitors, according to research presented at the NCRI Cancer Conference in Liverpool. Scientists have developed a new test to select which patients with ovarian cancer will benefit from new drugs called PARP inhibitors, according to research presented at the NCRI Cancer Conference in Liverpool.

8 November 2010

New link between growth factors and early prostate cancer found

A new study presented at the National Cancer Research Institute (NCRI) conference in Liverpool next week has found potential new biomarkers for very early prostate cancer in men with no symptoms of the disease. A new study presented at the National Cancer Research Institute (NCRI) conference in Liverpool next week has found potential new biomarkers for very early prostate cancer in men with no symptoms of the disease.

6 November 2010

New imaging technique reveals if breast cancer treatments are working

CANCER RESEARCH UK scientists have developed a new imaging technique that can show when breast cancer treatment is working, weeks before current methods. The research is published in the British Journal of Cancer today. CANCER RESEARCH UK scientists have developed a new imaging technique that can show when breast cancer treatment is working, weeks before current methods. The research is published in the British Journal of Cancer today.

27 October 2010

Urine protein could pave the way for new prostate cancer test

Cancer Research UK scientists have shown that a protein in urine could be a powerful indicator of prostate cancer risk, according to a study published in PLoS ONE. Cancer Research UK scientists have shown that a protein in urine could be a powerful indicator of prostate cancer risk, according to a study published in PLoS ONE.

13 October 2010

• Health & Medicine

Government announces new 'Flexi-scope' bowel screening test

The government announced revolutionary new bowel cancer screening after a 16-year clinical trial, revealed that it could save up to 3,000 lives a year. The government announced revolutionary new bowel cancer screening after a 16-year clinical trial, revealed that it could save up to 3,000 lives a year.

5 October 2010

• Health & Medicine

We’re delighted the Government has committed to improve bowel screening

4 October 2010

• Health & Medicine

Single PSA test at age 60 provides an indication of future prostate cancer risk

A prostate antigen level test at age 60 appears to provide an indication of a man's lifetime risk of being diagnosed and dying from prostate cancer. A prostate antigen level test at age 60 appears to provide an indication of a man's lifetime risk of being diagnosed and dying from prostate cancer.

16 September 2010